229 related articles for article (PubMed ID: 21156341)
1. EMAS position statement: Managing the menopause in the context of coronary heart disease.
Schenck-Gustafsson K; Brincat M; Erel CT; Gambacciani M; Lambrinoudaki I; Moen MH; Tremollieres F; Vujovic S; Rozenberg S; Rees M;
Maturitas; 2011 Jan; 68(1):94-7. PubMed ID: 21156341
[TBL] [Abstract][Full Text] [Related]
2. Invited Commentary: Hormone therapy risks and benefits--The Women's Health Initiative findings and the postmenopausal estrogen timing hypothesis.
Banks E; Canfell K
Am J Epidemiol; 2009 Jul; 170(1):24-8. PubMed ID: 19468078
[TBL] [Abstract][Full Text] [Related]
3. EMAS position statement: Managing menopausal women with a personal or family history of VTE.
Tremollieres F; Brincat M; Erel CT; Gambacciani M; Lambrinoudaki I; Moen MH; Schenck-Gustafsson K; Vujovic S; Rozenberg S; Rees M;
Maturitas; 2011 Jun; 69(2):195-8. PubMed ID: 21489728
[TBL] [Abstract][Full Text] [Related]
4. Update: estrogen and estrogen plus progestin therapy in the care of women at and after the menopause.
Davey DA
Womens Health (Lond); 2012 Mar; 8(2):169-89. PubMed ID: 22375720
[TBL] [Abstract][Full Text] [Related]
5. Menopause and stroke and the effects of hormonal therapy.
Lobo RA
Climacteric; 2007 Oct; 10 Suppl 2():27-31. PubMed ID: 17882669
[TBL] [Abstract][Full Text] [Related]
6. EMAS position statement: managing obese postmenopausal women.
Lambrinoudaki I; Brincat M; Erel CT; Gambacciani M; Moen MH; Schenck-Gustafsson K; Tremollieres F; Vujovic S; Rees M; Rozenberg S
Maturitas; 2010 Jul; 66(3):323-6. PubMed ID: 20434858
[TBL] [Abstract][Full Text] [Related]
7. Hormones and cardiovascular health in women.
ESHRE Capri Workshop Group
Hum Reprod Update; 2006; 12(5):483-97. PubMed ID: 16807276
[TBL] [Abstract][Full Text] [Related]
8. [Hormone replacement therapy of menopause, heart and blood vessels].
Kuttenn F; Gerson M
Arch Mal Coeur Vaiss; 2001 Jul; 94(7):685-9. PubMed ID: 11494629
[TBL] [Abstract][Full Text] [Related]
9. Global consensus statement on menopausal hormone therapy.
de Villiers TJ; Gass ML; Haines CJ; Hall JE; Lobo RA; Pierroz DD; Rees M
Climacteric; 2013 Apr; 16(2):203-4. PubMed ID: 23488524
[TBL] [Abstract][Full Text] [Related]
10. Hormone therapy: making decisions in the face of uncertainty.
Peterson HB; Thacker SB; Corso PS; Marchbanks PA; Koplan JP
Arch Intern Med; 2004 Nov; 164(21):2308-12. PubMed ID: 15557408
[No Abstract] [Full Text] [Related]
11. [Hormone substitution therapy in menopause and risk of breast cancer].
Colin C
Rev Fr Gynecol Obstet; 1991 Jan; 86(1):27-8. PubMed ID: 2068481
[TBL] [Abstract][Full Text] [Related]
12. Implications of recent clinical trials of postmenopausal hormone therapy for management of cardiovascular disease.
Rossouw JE
Ann N Y Acad Sci; 2006 Nov; 1089():444-53. PubMed ID: 17261787
[TBL] [Abstract][Full Text] [Related]
13. Patch instead of pill: a safer menopausal estrogen?
Cushman M
Arterioscler Thromb Vasc Biol; 2010 Feb; 30(2):136-7. PubMed ID: 20089948
[No Abstract] [Full Text] [Related]
14. Hormone replacement therapy and thrombotic risk: beauty is only skin deep.
Rosendaal FR
Nat Clin Pract Cardiovasc Med; 2008 Nov; 5(11):684-5. PubMed ID: 18797429
[TBL] [Abstract][Full Text] [Related]
15. Effect of NFE2L2 genetic polymorphism on the association between oral estrogen therapy and the risk of venous thromboembolism in postmenopausal women.
Bouligand J; Cabaret O; Canonico M; Verstuyft C; Dubert L; Becquemont L; Guiochon-Mantel A; Scarabin PY;
Clin Pharmacol Ther; 2011 Jan; 89(1):60-4. PubMed ID: 21107315
[TBL] [Abstract][Full Text] [Related]
16. [Menopause, hormonal replacement therapy, and coronary disease].
Gebara OC; Wajngarten M; Barretto AC; Bellotti G
Arq Bras Cardiol; 1995 Apr; 64(4):355-8. PubMed ID: 7495396
[No Abstract] [Full Text] [Related]
17. [Hormone replacement therapy of menopause. When to begin? When to stop?].
Tabaste JL
Contracept Fertil Sex; 1997 Apr; 25(4):285-7. PubMed ID: 9229518
[No Abstract] [Full Text] [Related]
18. Postmenopausal hormone therapy and risk of idiopathic venous thromboembolism: results from the E3N cohort study.
Canonico M; Fournier A; Carcaillon L; Olié V; Plu-Bureau G; Oger E; Mesrine S; Boutron-Ruault MC; Clavel-Chapelon F; Scarabin PY
Arterioscler Thromb Vasc Biol; 2010 Feb; 30(2):340-5. PubMed ID: 19834106
[TBL] [Abstract][Full Text] [Related]
19. [Hormone replacement therapy and breast cancer--any news?].
Holli K
Duodecim; 1999; 115(2):101-2. PubMed ID: 11830839
[No Abstract] [Full Text] [Related]
20. [Hormone replacement therapy and cardiovascular risk].
Maffei S; De Caterina R
G Ital Cardiol; 1996 Aug; 26(8):899-940. PubMed ID: 9005173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
